Prescription Information Modernization Act of 2025

This bill allows drug manufacturers to provide FDA-approved prescribing information exclusively through digital means, while requiring them to offer paper copies upon request without additional cost. It directly affects prescribers (like doctors) and dispensers (like pharmacists), ensuring they can choose their preferred format for receiving drug information. Key provisions include a 2-year transition period before the digital shift takes effect, mandatory manufacturer options for paper requests, and rules to minimize economic impacts on healthcare providers. The law maintains current FDA labeling requirements while modernizing how drug information is delivered.